Melissa M. Coughlin - Concepedia

Author

Melissa M. Coughlin

Centers for Disease Control and Prevention ORCID

Also Known As

Dr. Melissa M Coughlin, Hepatitis of Unknown Etiology Group, Melissa Coughlin, Melissa M Coughlin, Melissa M. Coughlin

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention University of Illinois Chicago Loyola University Chicago Purdue University West Lafayette Nigeria Centre for Disease Control

About

Melissa M. Coughlin is an author at Centers for Disease Control and Prevention specializing in medicine, virology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.4K
2	Public Health	4	4	456
3	Engineering	1	1	67
4	Natural Sciences	1	1	524
5	Biochemistry	1	1	524

Melissa M. Coughlin

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication Kiira Ratia, Scott D. Pegan, Jun Takayama, Proceedings of the National Academy of Sciences Viral ReplicationMolecular BiologyAntiviral DrugViral Structural ProteinChemical Biology	2008	524
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020 Wesley H. Self, Mark W. Tenforde, William B. Stubblefield, MMWR Morbidity and Mortality Weekly Report Viral DiagnosticsCovid-19 EpidemiologyHealth Care PersonnelCovid-19Diagnostic Test	2020	208
Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing Hatem A. Elshabrawy, Melissa M. Coughlin, Susan C. Baker, PLoS ONE Viral PathogenesisImmunologyViral Structural ProteinImmunotherapyHuman Monoclonal Antibodies	2012	192
Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee Manish Patel, Natalie J. Thornburg, William B. Stubblefield, JAMA	2020	151
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020 Wesley H. Self, Mark W. Tenforde, William B. Stubblefield, MMWR Morbidity and Mortality Weekly Report Viral DiagnosticsCovid-19 EpidemiologyCovid-19Diagnostic TestApril–august 2020	2020	151
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, April 2021–September 2022 Jefferson M. Jones, Irene Molina Manrique, Mars Stone, MMWR Morbidity and Mortality Weekly Report	2023	144
Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors Arun K. Ghosh, Gangli Gong, Valerie Grum‐Tokars, Bioorganic & Medicinal Chemistry Letters MedicineImmunologyAntiviral ResponseAntiviral Drug DevelopmentVirology	2008	135
Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease Arun K. Ghosh, Jun Takayama, Yoann Aubin, Journal of Medicinal Chemistry	2009	134
Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse® Melissa M. Coughlin, Gin Lou, Osvaldo Martinez, Virology ImmunologyAntiviral ResponseVirologyAntibody ScreeningAntibody Engineering	2006	74
Phytoremediation of Soil Contaminated with Used Motor Oil: I. Enhanced Microbial Activities from Laboratory and Growth Chamber Studies Elena Dominguez-Rosado, John Pichtel, Melissa M. Coughlin Environmental Engineering Science EngineeringMotor OilSoil PollutionUsed Motor OilBioremediation	2004	67

Page 1